This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 47/1/122    most recent 01.HYP.0000196272.79321.11v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brassard, P. Articles by Schiffrin, E. L. Search for Related Content PubMed PubMed Citation Articles by Brassard, P. Articles by Schiffrin, E. L. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure Hazardous Substances DB HYDRALAZINE HYDROCHLORIDE LOSARTAN POTASSIUM Related Collections Remodeling ACE/Angiotension receptors

(Hypertension. 2006;47:122.)
© 2006 American Heart Association, Inc.

Original Articles

Role of Angiotensin Type-1 and Angiotensin Type-2 Receptors in the Expression of Vascular Integrins in Angiotensin II–Infused Rats

From the Experimental Hypertension Laboratory (P.B., F.A., E.L.S.) and Laboratory of Cellular Biology of Hypertension (G.T.), Canadian Institutes of Health Research Multidisciplinary Research Group on Hypertension, Clinical Research Institute of Montreal, Montreal, Quebec, Canada.

Correspondence to Ernesto L. Schiffrin, Clinical Research Institute of Montreal, 110 Pine Ave West, Montreal, Quebec, Canada H2W 1R7. E-mail ernesto.schiffrin{at}ircm.qc.ca

Angiotensin II plays an important role in vascular remodeling through effects that involve, in part, interactions of vascular smooth muscle cells with extracellular matrix via integrins, which belong to a family of transmembrane receptors. We hypothesized that angiotensin (Ang) II regulates expression of vascular integrins and their ligands in experimental hypertension. Rats were infused subcutaneously with Ang II and received angiotensin type-1 (AT₁) receptor blocker losartan, the AT₁/angiotensin type-2 (AT₂) [Sar¹-Ile⁸]-Ang II, or the vasodilator hydralazine for 7 days. Osteopontin and integrin subunit expression were evaluated immunohistochemically. Ang II enhanced vascular ₈, ß₁, ß₃ integrins and osteopontin expression, which were significantly reduced by losartan, [Sar¹-Ile⁸]-Ang II, and hydralazine. Although Ang II increased vascular ₅ subunit expression, this was additionally increased by losartan. Losartan was the only treatment that induced ₁ subunit expression. These results demonstrate that AT₁ and AT₂ receptors have countervailing effects on vascular integrin subunit expression that may influence their effects on vascular remodeling and extracellular matrix composition.

Key Words: renin-angiotensin system • aorta • extracellular matrix • hypertension • osteopontin

This article has been cited by other articles:

				H. Louis, A. Kakou, V. Regnault, C. Labat, A. Bressenot, J. Gao-Li, H. Gardner, S. N. Thornton, P. Challande, Z. Li, et al. Role of {alpha}1beta1-integrin in arterial stiffness and angiotensin-induced arterial wall hypertrophy in mice Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2597 - H2604. [Abstract] [Full Text] [PDF]